Hypoxia-induced IL-32β increases glycolysis in breast cancer cells
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 356 (2) , 800-808
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (NRF-2012R1A2A1A03003709)
This publication has 38 references indexed in Scilit:
- Functional Metabolic Screen Identifies 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4 as an Important Regulator of Prostate Cancer Cell SurvivalCancer Discovery, 2012
- Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant ResponsesScience, 2011
- Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cellsOncotarget, 2011
- Inflammatory Cytokines IL-32 and IL-17 Have Common Signaling Intermediates despite Differential Dependence on TNF-Receptor 1The Journal of Immunology, 2011
- HIF-1: upstream and downstream of cancer metabolismCurrent Opinion in Genetics & Development, 2010
- IL-32–dependent effects of IL-1β on endothelial cell functionsProceedings of the National Academy of Sciences, 2009
- Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1Molecular and Cellular Biology, 2007
- Tumor hypoxia and cancer progressionCancer Letters, 2006
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxiaCell Metabolism, 2006
- HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumptionCell Metabolism, 2006